{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:31:46Z","timestamp":1790699506027,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Management of hypotension is a fundamental part of pediatric critical care, with cardiovascular support in the form of fluids or vasoactive drugs offered to every hypotensive child. However, optimal blood pressure (BP) targets are unknown. The PRotocolised Evaluation of PermiSSive BP Targets Versus Usual CaRE (PRESSURE) trial aims to evaluate the clinical and cost-effectiveness of a permissive mean arterial pressure (MAP) target of greater than a fifth centile for age compared with usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>Pragmatic, open, multicenter, parallel-group randomized control trial (RCT) with integrated economic evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>Eighteen PICUs across the United Kingdom.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>Infants and children older than 37 weeks corrected gestational age to 16 years accepted to a participating PICU, on mechanical ventilation and receiving vasoactive drugs for hypotension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>Adjustment of hemodynamic support to achieve a permissive MAP target greater than fifth centile for age during invasive mechanical ventilation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>Randomization is 1:1 to a permissive MAP target or usual care, stratified by site and age group. Due to the emergency nature of the treatment, approaching patients for written informed consent will be deferred until after randomization. The primary clinical outcome is a composite of death and days of ventilatory support at 30 days. Baseline demographics and clinical status will be recorded as well as daily measures of BP and organ support, and discharge outcomes. This RCT received Health Research Authority approval (reference 289545), and a favorable ethical opinion from the East of England\u2014Cambridge South Research Ethics Committee on May 10, 2021 (reference number 21\/EE\/0084). The trial is registered and has an International Standard RCT Number (reference 20609635).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Trial findings will be disseminated in U.K. national and international conferences and in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003516","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:03:43Z","timestamp":1713351823000},"page":"629-637","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Protocol for a Randomized Controlled Trial to Evaluate a Permissive Blood Pressure Target Versus Usual Care in Critically Ill Children with Hypotension (PRESSURE)"],"prefix":"10.1097","volume":"25","author":[{"given":"Robert","family":"Darnell","sequence":"first","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna","family":"Brown","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Laing","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Edwards","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Manning","sequence":"additional","affiliation":[{"name":"School of Healthcare, College of Life Sciences, University of Leicester, Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Peters","sequence":"additional","affiliation":[{"name":"Infection, Immunity and Inflammation, University College London Great Ormond Street Institute of Child Health, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmanabhan","family":"Ramnarayan","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, St Mary\u2019s Campus, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiran","family":"Ray","sequence":"additional","affiliation":[{"name":"Infection, Immunity and Inflammation, University College London Great Ormond Street Institute of Child Health, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia","family":"Sadique","sequence":"additional","affiliation":[{"name":"Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby R.","family":"Scholefield","sequence":"additional","affiliation":[{"name":"Department of Paediatric Critical Care Medicine, Hospital for Sick Children, University Avenue, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"Shortt","sequence":"additional","affiliation":[{"name":"Patient representative, c\/o Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamprini","family":"Lampro","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Au","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy M.","family":"Rowan","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mouncey","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Inwald","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Protocolised Evaluation of Permissive Blood Pressure Targets Versus Usual Care (PRESSURE) Trial Investigators on behalf of the U.K. Paediatric Critical Care Society Study Group (PCCS-SG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MCC.0000000000000205","article-title":"Haemodynamic and ventilator management in patients following cardiac arrest.","volume":"21","author":"Topjian","year":"2015","journal-title":"Curr Opin Crit Care"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00134-017-4701-8","article-title":"Prediction of pediatric sepsis mortality within 1\u2009h of intensive care admission.","volume":"43","author":"Schlapbach","year":"2017","journal-title":"Intensive Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PCC.0000000000000385","article-title":"Timing of death in children referred for intensive care with severe sepsis: Implications for interventional studies.","volume":"16","author":"Cvetkovic","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00134-017-5017-4","article-title":"Age-associated blood pressure distributions in paediatric intensive care units differ from healthy children.","volume":"44","author":"Abdelrazeq","year":"2018","journal-title":"Intensive Care Med"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamapediatrics.2017.4540","article-title":"Association between fluid balance and outcomes in critically ill children: A systematic review and meta-analysis.","volume":"172","author":"Alobaidi","year":"2018","journal-title":"JAMA Pediatr"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/PCC.0000000000003099","article-title":"The United Kingdom Pediatric Critical Care Society Study Group: The 20-year journey toward pragmatic, randomized clinical trials.","volume":"23","author":"Peters","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/PCC.0000000000002197","article-title":"Executive summary: Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1991.03470090076035","article-title":"Role of early fluid resuscitation in pediatric septic shock.","volume":"266","author":"Carcillo","year":"1991","journal-title":"JAMA"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.2008-1967","article-title":"Mortality and functional morbidity after use of PALS\/APLS by community physicians.","volume":"124","author":"Carcillo","year":"2009","journal-title":"Pediatrics"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1542\/peds.2010-2895","article-title":"Implementation of goal-directed therapy for children with suspected sepsis in the emergency department.","volume":"127","author":"Cruz","year":"2011","journal-title":"Pediatrics"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1542\/peds.2012-0094","article-title":"Adherence to PALS sepsis guidelines and hospital length of stay.","volume":"130","author":"Paul","year":"2012","journal-title":"Pediatrics"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"e20154153","DOI":"10.1542\/peds.2015-4153","article-title":"High reliability pediatric septic shock quality improvement initiative and decreasing mortality.","volume":"138","author":"Lane","year":"2016","journal-title":"Pediatrics"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.2018.9071","article-title":"Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis.","volume":"320","author":"Evans","year":"2018","journal-title":"JAMA"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock.","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00134-016-4237-3","article-title":"Higher versus lower blood pressure targets for vasopressor therapy in shock: A multicentre pilot randomized controlled trial.","volume":"42","author":"Lamontagne","year":"2016","journal-title":"Intensive Care Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00134-017-5016-5","article-title":"Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock.","volume":"44","author":"Lamontagne","year":"2018","journal-title":"Intensive Care Med"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2020.0930","article-title":"Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial.","volume":"323","author":"Lamontagne","year":"2020","journal-title":"JAMA"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: Designing trials that are fit for purpose.","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.PCC.0000257039.32593.DC","article-title":"Analysis of the evidence for the lower limit of systolic and mean arterial pressure in children.","volume":"8","author":"Haque","year":"2007","journal-title":"Pediatr Crit Care Med"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"e008522","DOI":"10.1136\/bmjopen-2015-008522","article-title":"How parents and practitioners experience research without prior consent (deferred consent) for emergency research involving children with life threatening conditions: A mixed method study.","volume":"5","author":"Woolfall","year":"2015","journal-title":"BMJ Open"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2022.3367","article-title":"Effect of high-flow nasal cannula therapy vs continuous positive airway pressure following extubation on liberation from respiratory support in critically ill children: A randomized clinical trial.","volume":"327","author":"Ramnarayan","year":"2022","journal-title":"JAMA"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2022.9615","article-title":"Effect of high-flow nasal cannula therapy vs continuous positive airway pressure therapy on liberation from respiratory support in acutely ill children admitted to pediatric critical care units: A randomized clinical trial.","volume":"328","author":"Ramnarayan","year":"2022","journal-title":"JAMA"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24230","article-title":"Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: The GASTRIC feasibility study.","volume":"24","author":"Tume","year":"2020","journal-title":"Health Technol Assess"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/archdischild-2018-314924","article-title":"Restricted fluid bolus volume in early septic shock: Results of the fluids in shock pilot trial.","volume":"104","author":"Inwald","year":"2019","journal-title":"Arch Dis Child"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-019-2354-4","article-title":"Permissive versus restrictive temperature thresholds in critically ill children with fever and infection: A multicentre randomized clinical pilot trial.","volume":"23","author":"Peters","year":"2019","journal-title":"Crit Care"},{"key":"R29-20250502","first-page":"28","article-title":"A qualitative feasibility study to inform a randomised controlled trial of fluid bolus therapy in septic shock.","volume":"103","author":"O\u2019Hara","year":"2018","journal-title":"Arch Dis Child"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/sim.6355","article-title":"Power and sample size calculations for the Wilcoxon-Mann-Whitney Test in the presence of missing observations due to death.","volume":"34","author":"Matsouaka","year":"2015","journal-title":"Stat Med"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: Greater precision but with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"JAMA"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1097\/00003246-200007000-00072","article-title":"Relationship of Pediatric Overall Performance Category and Pediatric Cerebral Performance Category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments.","volume":"28","author":"Fiser","year":"2000","journal-title":"Crit Care Med"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/11587350-000000000-00000","article-title":"Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation.","volume":"9","author":"Stevens","year":"2010","journal-title":"Appl Health Econ Health Policy"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2014reporting of subgroup analyses in clinical trials.","volume":"357","author":"Wang","year":"2007","journal-title":"N Engl J Med"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.2013.285063","article-title":"How to use a subgroup analysis: Users\u2019 guide to the medical literature.","volume":"311","author":"Sun","year":"2014","journal-title":"JAMA"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:44:05Z","timestamp":1746193445000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003516","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}